Nemolizumab (CIM331) is a humanized antihuman interleukin-31 receptor A monoclonal antibody that inhibits the binding of interleukin-31 (IL-31) to its receptor and subsequent signal transduction. Nemolizumab can used be in research of atopic dermatitis (AD).
Purity:
95.0%
CAS Number:
[1476039-58-3]
Target:
IL Receptor/Related
* VAT and and shipping costs not included. Errors and price changes excepted